BW

Brian H. White

GL Glaxosmithkline: 4 patents #75 of 646Top 15%
TT Tarveda Therapeutics: 4 patents #7 of 19Top 40%
IP Infinity Pharmaceuticals: 3 patents #41 of 76Top 55%
Overall (All Time): #408,955 of 4,157,543Top 10%
12
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11458206 Targeted conjugates and particles and formulations thereof Rossitza G. Alargova, Mark T. Bilodeau, Craig A. Dunbar, Sudhakar Kadiyala, Rajesh R. Shinde +4 more 2022-10-04
11241500 HSP90-targeting conjugates and formulations thereof Benoît Moreau, Mark T. Bilodeau, Mary Simcox, Kerry Whalen, Leila Alland +2 more 2022-02-08
10624967 Targeted conjugates and particles and formulations thereof Rossitza G. Alargova, Mark T. Bilodeau, Craig A. Dunbar, Sudhakar Kadiyala, Rajesh R. Shinde +4 more 2020-04-21
10590135 Substituted bridged urea analogs as sirtuin modulators Charles A. Blum, Richard D. Caldwell, Rebecca Casaubon, Jeremy S. Disch, Ryan Michael Fox +6 more 2020-03-17
10322191 Targeted conjugates and particles and formulations thereof Rossitza G. Alargova, Mark T. Bilodeau, Craig A. Dunbar, Sudhakar Kadiyala, Rajesh R. Shinde +4 more 2019-06-18
9879025 Transfer hydrogenation of cyclopamine analogs Daniel Genov, Brian C. Austad 2018-01-30
9834558 Substituted bridged urea analogs as sirtuin modulators Charles A. Blum, Richard D. Caldwell, Rebecca Casaubon, Jeremy S. Disch, Ryan Michael Fox +6 more 2017-12-05
9765075 Substituted bridged urea analogs as sirtuin modulators Charles A. Blum, Richard D. Caldwell, Rebecca Casaubon, Jeremy S. Disch, Ryan Michael Fox +5 more 2017-09-19
9750818 Targeted conjugates and particles and formulations thereof Rossitza G. Alargova, Mark T. Bilodeau, Craig A. Dunbar, Sudhakar Kadiyala, Rajesh R. Shinde +4 more 2017-09-05
9394313 Transfer hydrogenation of cyclopamine analogs Daniel Genov, Brian C. Austad 2016-07-19
9376447 Transfer hydrogenation of cyclopamine analogs Daniel Genov, Brian C. Austad 2016-06-28
9326986 Quinazolinone, quinolone and related analogs as sirtuin modulators Chi B. Vu, Christopher Oalmann, Robert B. Perni 2016-05-03